2976 Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Arthritis and

Musculoskeletal and Skin Diseases Advisory

Council.

Open: 8:30 am to 12:00 pm.

Agenda: The meeting will be open to the

public to discuss administrative details

relating to Council business and special

reports.

Place: 9000 Rockville Pike, Building 31C,

Conference Room 6, Bethesda, MD 20892.

Closed: 1:00 pm to 5:00 pm.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: 9000 Rockville Pike, Building 31C,

Conference Room 6, Bethesda, MD 20892.

Contact Person: Steven J. Hausman, Phd,

Deputy Director, NIAMS/NIH, Bldg. 31,

Room 4C–32, 31 Center Dr, MSC 2350,

Bethesda, MD 20892–2350.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: January 5, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1151 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: January 17, 2000.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Gloria B. Levin, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435–

1017, leving@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: January 17, 2000.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Gloria B. Levin, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435–

1017, leving@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: January 20, 2000.

Time: 11 a.m. to 12:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Michael Micklin, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel, MBC–2.

Date: January 24, 2000.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Rona L. Hirschberg, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4186,

MSC 7808, Bethesda, MD 20892, (301) 435–

1150.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Oncological Sciences

Initial Review Group, Pathology B Study

Section.

Date: January 28–30, 2000.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Keystone Resort, Keystone, CO

80222., (Telephone Conference Call).

Contact Person: Martin L. Padarathsingh,

PHD, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 4146, MSC 7804, Bethesda, MD 20892,

(301) 435–1717.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: January 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1135 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: January 18, 2000.

Time: 12:00 PM to 1:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Sally Ann Amero, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 60461,

MSC 7890, Bethesda, MD 20892, (301) 435–

1159, ameros@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; Clinical Research, 93.333, 93.337,

93.393–93.396, 93.837–93.844, 93.846–

93.878, 93.892, 93.893, National Institutes of

Health, HHS)